SCHEMBL7876016

SCHEMBL7876016

Cc1[nH]c(=O)c(CC(c2cccc(F)c2)C2CC2)nc1CC(=O)NCCONC(=N)N

nearest known ligand 0.37

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.31
REN P00797 1/20 0.31
CCL5 P13501 1/20 0.31
KCNH2 Q12809 1/20 0.31
CYP2C9 P11712 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876037 0.90 PDE2A (0.31)
SCHEMBL7872474 0.87 USP2 (0.34)
SCHEMBL7876222 0.87 OPRM1 (0.37)
SCHEMBL7867175 0.86 SLC6A2 (0.31)
SCHEMBL7867166 0.81 NOS1 (0.36) NOS1TP53
SCHEMBL3244154 0.79 F2 (0.42)
SCHEMBL7874304 0.73
SCHEMBL7876040 0.73
SCHEMBL7867229 0.73 F2 (0.44) TP53
SCHEMBL7876212 0.73 F2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP claimed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO claimed
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP disclosed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO disclosed